Tadaflo

Product Overview

Tadaflo is a pharmaceutical formulation containing Tadalafil as its active component, a selective inhibitor of phosphodiesterase type 5 (PDE5). Clinically proven for managing erectile dysfunction (ED) and benign prostatic hyperplasia (BPH) symptoms, this medication is manufactured under strict quality controls to provide effective therapeutic outcomes for enhanced sexual function and urinary symptom relief.

Primary Indications

Tadaflo is clinically indicated for:

• Treatment of male erectile dysfunction through enhanced penile blood flow during sexual stimulation
• Management of lower urinary tract symptoms secondary to BPH, including urinary frequency, urgency, and incomplete bladder emptying

Administration Guidelines

For optimal therapeutic results:

1. Administer orally with water, with or without food, as prescribed
2. For ED: Take approximately 30 minutes prior to anticipated sexual activity
3. For BPH: Maintain consistent daily dosing at the same time
4. Swallow tablets whole without crushing or chewing

Mechanism of Action

Tadaflo exerts its therapeutic effects through selective PDE5 inhibition, which:

• Enhances nitric oxide-mediated vasodilation
• Promotes smooth muscle relaxation in the corpus cavernosum and prostate
• Improves hemodynamic parameters in the genitourinary system

Dosing Protocol

Standard therapeutic regimens include:

• ED management: 10-20 mg as needed (maximum frequency: once daily)
• BPH treatment: 5 mg once daily maintenance therapy

Individualized dosing adjustments may be required based on clinical response and tolerability.

Therapeutic Advantages

Tadaflo offers multiple clinical benefits:

• Significant improvement in erectile function parameters
• Effective relief of BPH-related urinary symptoms
• Extended duration of action (up to 36 hours)
• Convenient dosing options for both indications
• Improved quality of life measures

Adverse Effect Profile

Common treatment-emergent effects may include:

• Cephalgia (headache)
• Facial flushing
• Dyspepsia
• Myalgia/back pain
• Nasal congestion

These typically demonstrate mild intensity and transient nature.

Clinical Considerations

Important prescribing considerations:

• Absolute contraindication with nitrate therapy
• Caution required with alpha-adrenergic antagonists
• Requires cardiovascular risk assessment prior to initiation
• Special populations require dose adjustments

Important Safety Information

Tadaflo is contraindicated in:

• Hypersensitivity to tadalafil or excipients
• Patients receiving organic nitrates
• Severe hepatic impairment
• Women and pediatric populations

Concomitant grapefruit products should be avoided.

Storage Requirements

Proper storage conditions:

• Maintain at controlled room temperature (15-30°C)
• Protect from moisture and light
• Keep in original packaging
• Secure storage away from children

Medical Disclaimer

This information is provided for educational purposes only and does not constitute medical advice. While we strive for accuracy, this content should not replace professional medical consultation. Healthcare providers should be consulted for:

• Individualized treatment plans
• Comprehensive risk assessments
• Management of potential drug interactions
• Evaluation of contraindications

This information supports but does not replace the physician-patient relationship.